Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults
NCT07000916 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2025-06-03
Summary
Population:
Juvenile idiopathic arthritis (JIA), rheumatoid arthritis (RA) and seronegative / psoriatic / undifferentiated arthritis (UA), systemic lupus erythematosus (SLE) or diffuse systemic sclerosis dSS).
Naïve to basic treatment OR treated for ≤ 3 months; except for patients with JIA.
These 5 cohorts will be subject to standardized clinical monitoring.
Conditions
- Juvenile Idiopathic Arthritis
- Rheumatoid Arthritis
- Psoriatic Arthritis
- Systemic Lupus Erythematosus
- Diffuse Systemic Sclerosis
- Seronegative Arthritis
Sponsors & Collaborators
-
Université Catholique de Louvain
lead OTHER
Principal Investigators
-
Patrick Durez, Pr · UCLouvain - IREC
Eligibility
- Min Age
- 2 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-09-11
- Primary Completion
- 2028-03-31
- Completion
- 2028-03-31
Countries
- Belgium
Study Locations
More Related Trials
-
Study of Antibodies to Anti-TNF Agents in Juvenile Idiopathic Arthritis
NCT01436019 ·Status: UNKNOWN
-
Differentiate Children Septic and Inflammatory Arthritis by Comparative Analysis
NCT03827759 ·Status: TERMINATED
-
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Case-control
NCT02890147 ·Status: COMPLETED
-
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases:
NCT02890121 ·Status: COMPLETED
-
Lymphocyte Sub-populations and Auto Immune Diseases
NCT03901664 ·Status: COMPLETED
-
Long-Term Outcomes in SLE at Peking University People's Hospital
NCT07005479 ·Status: RECRUITING
-
Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism
NCT05961267 ·Status: COMPLETED
-
Rheumatology Patient Registry and Biorepository
NCT04402086 ·Status: RECRUITING
-
PRediction Of Flares In Lupus With autoantibodiEs and Chemokines
NCT04951427 ·Status: UNKNOWN
-
ILT-101 in Patients With Active Moderate to Severe Systemic Lupus Erythematosus (SLE)
NCT02955615 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus
NCT02725515 ·Status: COMPLETED ·Phase: PHASE2
-
Does Belimumab Modify the Natural History of SLE? A Propensity Score-matched, Real-world Study
NCT07056621 ·Status: RECRUITING
-
Immunome Project Consortium for Autoinflammatory Disorders
NCT03919110 ·Status: COMPLETED
-
Synergetic B-cell Immunomodulation in SLE - 2nd Study.
NCT03747159 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus
NCT01764594 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Systemic Lupus Erythematosus
NCT00001372 ·Status: RECRUITING
-
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Inception Cohort
NCT02890134 ·Status: COMPLETED
-
Molecular Diagnosis of Systemic Autoinflammatory Diseases
NCT05364294 ·Status: RECRUITING
-
Autoimmunity in Sisters of Lupus Patients
NCT01076101 ·Status: COMPLETED
-
Comparison of the Clinical Examination and the Joint Ultrasonography in Lupus Patients
NCT02922114 ·Status: COMPLETED ·Phase: NA
-
Clinical Risk Assessment of Cognitive Function in Systemic Autoimmune Diseases
NCT06029335 ·Status: UNKNOWN
-
Synergetic B-cell Immodulation in SLE
NCT02284984 ·Status: COMPLETED ·Phase: PHASE2
-
Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases
NCT04276701 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in Europe
NCT04397237 ·Status: UNKNOWN
-
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
NCT07175285 ·Status: RECRUITING